Sadot Group Inc.: Sadot Group Reports Second Quarter 2026 Financial Results

Sadot Group Inc. (Nasdaq:SDOT) reported Q2 2026 results for the quarter ended June 30, 2026. Revenue fell to $0.0 million from $246.6 million, with gross profit $0.0 million vs $11.0 million. Net income was $35.2 million, and adjusted EBITDA loss was $3.3 million. Sadot said TradeOS integration is deployed and generated about $1.0 million gross revenue in July. Nasdaq notified it it must evidence equity compliance by the Sept. 30, 2026 report.

Original reporting
Published Aug 14, 2026, 9:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$SDOT
Bearish
medium confidence
Mentioned
$SDOT
Relevance
7/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$SDOTBearishMed
01

Why it matters

The combination of weak reported operating metrics, very low cash, and explicit going-concern doubt increases probability of dilution or restructuring, while the conditional Nasdaq compliance creates a discrete catalyst window into the Sept. 30 filing.

02

Market read

This is a microcap risk-management story: conditional listing compliance plus going-concern language can dominate price action more than the early TradeOS monetization.

03

What to watch

The Nasdaq compliance determination is conditional on the Sept. 30 periodic report; traders should monitor the 10-Q/10-K equity trajectory and any capital-raise or restructuring details that could change dilution expectations.

Relevance 7/10Novelty 6/10Timing: after-hours today, ahead of Sept. 30 Nasdaq equity evidence deadline

Background

Sadot acquired the TradeOS commodity trading and risk management platform in June 2026 and is simultaneously addressing Nasdaq Capital Market continued listing requirements.

Company-level read

Ticker impact

$SDOTBearishMedium confidence
Context

Sadot reports Q2 2026 results with $0.0M revenue and $35.2M net income, plus Nasdaq compliance conditional on equity at the Sept. 30 filing.

Expected impact

Elevated downside tail risk into the Sept. 30 compliance evidence deadline; any stabilization in liquidity or clearer TradeOS traction could provide short-lived relief rallies.

Evidence & confidence

The release highlights continued listing uncertainty, cash of $0.1M, and going-concern doubt, while TradeOS revenue is preliminary and not yet reflected in Q2.

Market effects

Limited read-through to agri-food supply chain peers; more relevant as a case study in exchange listing and post-acquisition integration execution risk.

No clear regional spillover beyond US microcap listing sentiment.

Minimal global impact; TradeOS is deployed within Sadot’s trading operations.

Counterpoint

TradeOS is already deployed across desks and produced first commercial transactions in July, which could accelerate adoption and revenue once onboarding expands.

Key entities

  • Sadot Group Inc.

    Nasdaq-listed agri-food and commodity supply chain company reporting Q2 2026 results and TradeOS integration progress.

  • TradeOS platform

    Commodity trading and risk management platform acquired in June 2026 and deployed across Sadot trading operations.

  • Nasdaq Listing Rule 5550(b)(1)

    Minimum stockholders’ equity requirement; compliance is conditioned on evidence at the Sept. 30 periodic report filing.

Related articles

$SDOTHigh

Sadot Group Shares Surge on Debt Restructuring and AI Trading Strategy

Sadot Group (SDOT) shares rose 39.4% to $18.37 in pre-market trading due to debt restructuring and AI trading strategy. The company reset a convertible note's conversion price to $8, improving balance-sheet flexibility. It also integrated TradeOS and acquired TradeIQ for AI-driven commodity trading, generating $1M in preliminary revenue. A reverse stock split amplified volatility. SDOT regained Nasdaq compliance, reducing delisting risks.

$PMIMed

Biotech Gainers: PMI Revenue Growth, SDOT Earnings Surge, CAPR FDA Update, GRI Data Drive Gains

Picard Medical (PMI) rose 40% after reporting Q2 revenue growth of 39% to $3.0M. Sadot Group (SDOT) surged 100% despite zero revenue, with net income up to $35.2M. Capricor Therapeutics (CAPR) gained 11% after FDA extended review for deramiocel. GRI Bio (GRI) climbed 10% with Phase 2a data selected for ERS 2026. Biomea Fusion (BMEA) rose 14% after completing Phase 2 diabetes trial enrollment. Yarrow Bioscience (YARW) advanced 12% with Graves' disease trial updates.

$SDOTLow

Sadot Group Inc. (SDOT): Results of Operations and Financial Condition

Sadot Group Inc. (SDOT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Sadot Group Reports Second Quarter 2026 Financial Results Company Completes Integration of Acquired TradeOS Platform Across Its Trading Operations BURLESON, Texas, Aug. 14, 2026 (ACCESS NEWSWIRE) — Sadot Group Inc. (Nasdaq: SDOT) (“Sadot” or the “Company”), a global

$SDOTMed

Sadot Group Improves Balance Sheet With $4.3 Million in Debt-to-Equity Settlements, Announces New Chapter as an AI-Powered Technology Platform Company

Sadot Group Inc. (Nasdaq:SDOT) said it is transitioning from physical commodity trading operations to an AI-powered technology platform anchored by TradeOS and TradeIQ. Separately, it completed four debt-to-equity settlements, extinguishing about $4.3 million of outstanding debt and claims in exchange for SDOT shares with no cash.

$SDOTMed

Sadot Group (NASDAQ: SDOT) asks investors to back $200M financings and share changes

Sadot Group Inc. (NASDAQ: SDOT) filed a preliminary 2026 proxy seeking stockholder approval for a virtual annual meeting. Proposals include electing five directors, ratifying Kreit & Chiu CPA LLP, approving a 2026 Stock Incentive Plan for up to 3,000,000 shares, and authorizing capital-structure changes tied to $200M financings, including up to $100M convertible note conversions, reverse splits (5-for-1 to 250-for-1), and a $100M equity purchase facility.